About
Profile
We create breakthrough products – in diagnostics, medical devices, nutrition and branded generic pharmaceuticals – that help you, your family and your community lead healthier lives, full of unlimited possibilities. Today, 103,000 of us are working to
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
ABT
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Abbott Q2 results top consensus as base business offsets COVID impact
- Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
- Abbott seen reporting lower Q2 revenue, due in part to less COVID testing
- Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown
- Earnings week ahead: Tesla, Netflix, Johnson & Johnson, Bank of America and more
- Goldman Sachs sees rays of hope in underperforming health sector
- BTIG unveils top picks for rest of '23: D.R. Horton, CrowdStrike, DraftKings among names
- FDA approves Abbott dual-chamber leadless pacemaker Aveir DR
- Medicare revises guidance on drug price negotiations amid lawsuits
- Abbott gains expanded coverage for glucose monitoring device in France
- Abbott names Philip Boudreau CFO effective Sept. 1
- Abbott Laboratories declares $0.51 dividend
- Abbott alleges former scientist in its nutrition unit stole trade secrets
- Morgan Stanley's top medtech picks are Medtronic, Alphatec, Becton Dickinson
- Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics
- Abbott boasts of heart failure reduction data for CardioMEMS device
- Abbott, other baby-formula makers see FTC probe over collusion - report
- Abbott recalled baby formula claims tossed by federal judge
- Abbott gains approval of TactiFlex ablation catheter treatment
- Stereotaxis stock rises after pact with Abbott to improve abnormal heartbeat treatment
PEERS
Date | Price | Open | High | Low | Vol | Change | |||
---|---|---|---|---|---|---|---|---|---|
Apr 18 | 105.26 | 106.47 |
106.96
|
104.5
|
5.9M | -0.59% | |||
Apr 17 | 105.88 | 108.72 |
108.72
|
104.28
|
10.8M | -3.08% | |||
Apr 16 | 109.25 | 108.84 |
110.33
|
108.14
|
5.9M | 0.35% | |||
Apr 15 | 108.87 | 110.17 |
110.87
|
108.84
|
3.4M | -0.2% | |||
Apr 12 | 109.09 | 110.22 |
110.5
|
108.49
|
3.1M | -2.08% | |||
Apr 11 | 111.41 | 111.68 |
111.89
|
110.32
|
3.1M | 0.22% | |||
Apr 10 | 111.17 | 111.07 |
111.63
|
110.38
|
3.5M | -1.13% | |||
Apr 9 | 112.44 | 110.65 |
112.56
|
110.64
|
4.2M | 1.71% | |||
Apr 8 | 110.55 | 111.37 |
111.37
|
110.14
|
4.2M | -0.58% | |||
Apr 5 | 111.2 | 110.06 |
111.26
|
109.93
|
5.6M | 0.99% | |||
Apr 4 | 110.11 | 111.98 |
111.98
|
109.84
|
4.7M | -1.05% | |||
Apr 3 | 111.28 | 112.16 |
112.55
|
111.05
|
4.3M | -0.66% | |||
Apr 2 | 112.02 | 111.92 |
112.42
|
111.19
|
4.6M | -0.06% | |||
Apr 1 | 112.09 | 113.6 |
113.61
|
111.82
|
3.8M | -1.38% | |||
Mar 28 | 113.66 | 113.28 |
114.01
|
112.94
|
5.3M | 0.16% | |||
Mar 27 | 113.48 | 112.12 |
113.7
|
112.08
|
7.5M | 1.78% | |||
Mar 26 | 111.5 | 110.42 |
111.89
|
109.97
|
7.8M | 1.35% | |||
Mar 25 | 110.01 | 110.46 |
110.7
|
109.13
|
6.6M | -0.5% | |||
Mar 22 | 110.56 | 111.52 |
111.98
|
110.55
|
4.0M | -0.8% | |||
Mar 21 | 111.45 | 111.95 |
112.14
|
111.02
|
7.8M | -0.04% | |||
Mar 20 | 111.5 | 113 |
113.24
|
110.73
|
8.3M | -1.47% | |||
Mar 19 | 113.16 | 112.44 |
114.42
|
112.04
|
8.3M | 0.64% | |||
Mar 18 | 112.44 | 115.35 |
115.76
|
112.29
|
13.0M | -2.64% | |||
Mar 15 | 115.49 | 113.02 |
115.49
|
112.26
|
22.1M | -2.83% | |||
Mar 14 | 118.85 | 120.01 |
120.34
|
117.85
|
4.9M | -1.09% | |||
Mar 13 | 120.16 | 120.52 |
120.93
|
119.62
|
3.4M | -0.5% | |||
Mar 12 | 120.76 | 119.95 |
121.08
|
119.06
|
3.1M | 0.47% | |||
Mar 11 | 120.19 | 120.93 |
121.42
|
119.62
|
3.9M | -0.64% | |||
Mar 8 | 120.96 | 120.97 |
121.64
|
120.61
|
3.4M | 0.03% | |||
Mar 7 | 120.92 | 120.1 |
121.5
|
119.95
|
4.1M | 1.32% | |||
Mar 6 | 119.34 | 118.6 |
119.58
|
118.42
|
3.4M | 0.73% | |||
Mar 5 | 118.48 | 120.44 |
120.6
|
118.08
|
3.5M | -1.3% | |||
Mar 4 | 120.04 | 118.3 |
120.28
|
118.17
|
3.1M | 1.20% | |||
Mar 1 | 118.62 | 118.57 |
119.46
|
117.83
|
3.9M | -0.02% | |||
Feb 29 | 118.64 | 120.32 |
120.44
|
118.53
|
6.1M | -1.17% | |||
Feb 28 | 120.05 | 119.49 |
120.11
|
119.27
|
3.4M | 0.54% | |||
Feb 27 | 119.4 | 118.16 |
119.5
|
117.83
|
3.2M | 0.60% | |||
Feb 26 | 118.69 | 119.5 |
119.95
|
118.39
|
3.4M | -0.64% | |||
Feb 23 | 119.46 | 119.38 |
120.15
|
118.86
|
4.3M | 0.37% | |||
Feb 22 | 119.02 | 118.1 |
119.25
|
116.8
|
4.9M | 0.98% | |||
Feb 21 | 117.87 | 115.96 |
117.97
|
115.96
|
6.1M | 1.05% | |||
Feb 20 | 116.64 | 114.33 |
117.19
|
113.96
|
9.6M | 2.31% | |||
Feb 16 | 114.01 | 113.5 |
115.49
|
113.45
|
7.2M | 0.33% | |||
Feb 15 | 113.64 | 112.27 |
114.27
|
112.27
|
5.4M | 1.41% | |||
Feb 14 | 112.06 | 111.64 |
112.38
|
111.12
|
4.0M | 0.65% | |||
Feb 13 | 111.34 | 112.47 |
113.11
|
110.58
|
4.2M | -1.06% | |||
Feb 12 | 112.53 | 111.5 |
112.63
|
111.21
|
4.2M | 0.64% | |||
Feb 9 | 111.81 | 112.25 |
112.63
|
111.19
|
5.9M | -0.55% | |||
Feb 8 | 112.43 | 113.35 |
113.35
|
111.52
|
6.9M | -0.78% | |||
Feb 7 | 113.31 | 114.6 |
114.6
|
112.89
|
4.7M | -0.61% | |||
Feb 6 | 114 | 111.82 |
114.51
|
111.72
|
4.7M | 2.10% | |||
Feb 5 | 111.65 | 112.02 |
112.46
|
111.15
|
5.7M | -0.41% | |||
Feb 2 | 112.11 | 112.96 |
114.06
|
111.98
|
7.6M | -2.08% | |||
Feb 1 | 114.49 | 112.75 |
114.54
|
112
|
4.5M | 1.18% | |||
Jan 31 | 113.15 | 114 |
114.54
|
112.62
|
8.3M | -0.29% | |||
Jan 30 | 113.48 | 113.9 |
113.92
|
112.38
|
4.7M | 0.03% | |||
Jan 29 | 113.45 | 112.15 |
113.47
|
112.03
|
6.5M | 1.29% | |||
Jan 26 | 112.01 | 113.23 |
113.41
|
111.54
|
5.2M | -0.39% | |||
Jan 25 | 112.45 | 111.41 |
112.57
|
110.79
|
5.6M | 1.52% | |||
Jan 24 | 110.77 | 110.75 |
113.35
|
109.74
|
8.7M | 0% |